McNicoll Lewis & Vlak Starts ImmunoCellular Therapeutics (IMUC) at Buy
Tweet
Share
E-mailGet Alerts IMUC Hot Sheet
Price: $0.20 --0%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 17
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 17
Join SI Premium – FREE
McNicoll Lewis & Vlak initiates coverage on ImmunoCellular Therapeutics (OTC: IMUC) with a Buy. PT $4.50.
For an analyst ratings summary and ratings history on ImmunoCellular Therapeutics click here. For more ratings news on ImmunoCellular Therapeutics click here.
Shares of ImmunoCellular Therapeutics closed at $2.76 yesterday.
For an analyst ratings summary and ratings history on ImmunoCellular Therapeutics click here. For more ratings news on ImmunoCellular Therapeutics click here.
Shares of ImmunoCellular Therapeutics closed at $2.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts AMD (AMD) at Outperform
- JPMorgan Starts Select Water Solutions, Inc (WTTR) at Overweight
- Morgan Stanley Starts Adani Green Energy (ADANIGR:IN) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
